A PHARMACEUTICAL FORMULATION COMPRISING METFORMIN AND URSODEOXYCHOLIC ACID FOR THE TREATMENT OF FATTY LIVER DISEASE

摘要

The present invention is related to the combination of Metformin and Ursodeoxycholic acid (UDCA) for the treatment of fatty liver disease. It comprises Metformin in the range of 50mg to 1500mg, preferably 200mg to 1000mg, more preferably 250 mg to 500mg and Ursodeoxycholic acid in the range of 50 mg to 1500 mg, preferably 200 mg to 1000mg, more preferably 250 mg to 500mg.useful for the treatment of a variety of bacterial infections, along with pharmaceutically acceptable excipients.